Fundamental Analysis of Max Healthcare Institute Ltd. - Growth / Value Index
MAXHEALTH - Valuation Highlights
Valuation Analysis
Tremendous increasing in Book Value last 3 year
Tsr Value Index - Poor Score of 29.17
Expensive - Price to Intrinsic Value of 2.68
Price to Earning Ratio is 98.29 and EV to EBITDA is 55.68 suggesting that it is very expensive
Price to Book Ratio of 12.60 suggesting that it is very expensive
Valuation Key Ratios
Ratio | TTM | Latest FY | Yoy Change | MRQ | Screener/ About |
---|---|---|---|---|---|
Price to Earning | 97.79 | 99.09 | 31.62 % | ||
Price to Book | 12.53 | 11.36 | 20.00 % | 11.95 | |
Price to Sales | 14.94 | 15.17 | 2.98 % | ||
Enterprise Value to EBITDA Multiple | 56.43 | 18.26 % |
MAXHEALTH - Profitability Highlights
Profitability Analysis
All key Trailing Twelve Months Margin growing by 15 %
EBITDA is continuously increasing for last 3 Years
Good Return on Equity of 12.82% is achieved by the company
Good Net Margin of 15.27% is achieved by the company
Very Low Dividend Yield of 0 %
Profitability Key Ratios
Ratio | TTM | Latest FY | Yoy Change | MRQ | Screener/ About |
---|---|---|---|---|---|
Return On Equity | 12.82 | 11.47 | -8.82 % | 3.28 | |
Return On Asset | 8.35 | 7.07 | -19.77 % | 2.02 | |
Net Profit Margin | 15.27 | 15.31 | -21.76 % | 15.19 | |
Operating Profit Margin | 61.21 | 18.84 | -14.20 % | 25.79 | |
EBITDA Margin | 27.53 | 27.47 | -11.08 % | 27.59 |
Highlights
Market Cap | 1122.24 B |
Enterprise Value | 1145.73 B |
Price/Book TTM | 12.53 |
Outstanding Share | 972227 K |
Float/ Outstanding Share | 69.69% |
Dividend Yield | 0 % |
Share Holding
Guru Numbers
Price/Graham No | 7.21 |
Peter Lynch Ratio | 0.0169 |
Piotroski F Score | 6.00 |
Altman Z Score | 12.61 |
Sloan Ratio | 0.082 |
Peter Lynch Fair Value | 295.11 |
MAXHEALTH - Growth Highlights
Growth Analysis
Tsr Growth Index - Good Score of 78.82
Tremendous increasing trend in total sale last 3 year
Quarterly sales in last 5 years is trending up
Steady increase in Total Assets for last 3 Years
Growth Key Fields
Field | TTM | YoY Growth | QoQ Growth |
---|---|---|---|
Revenue | 7513.08 (Cr) | 30.01 % | 6.17 % |
Gross Profit | 5194.88 (Cr) | 178.79 % | 5.47 % |
EBITDA | 2068.14 (Cr) | 15.60 % | 0.158 % |
Net Profit | 1147.58 (Cr) | 1.72 % | 3.46 % |
EPS | 11.80 | 1.65 % | NA |
MAXHEALTH - Stability Highlights
Stability Analysis
Tsr Stability Index - Good Score of 70.31
Altman Z Score of 12.67 suggests good Stability
Stability Key Ratios
Ratio | Latest FY | Yoy Change | MRQ | Screener/ About |
---|---|---|---|---|
Debt to Equity Ratio | 0.321 | 130.35 % | 0.268 | |
Cash Ratio | 0.376 | -57.29 % | ||
Quick Ratio | 0.819 | -37.08 % | 0.819 | |
Shareholders Equity | 61.66 | -12.00 % | ||
Debt to EBITDA | 1.56 | 122.31 % |
Historical Valuation Ratios of Max Healthcare Institute Ltd.
Historical Valuation Ratios
Loading ...

Historical Profitability Ratios of Max Healthcare Institute Ltd.
Historical Profitability Ratios
Loading ...

Historical Efficiency Ratios of Max Healthcare Institute Ltd.
Historical Efficiency Ratios
Loading ...

Historical Solvency Ratios of Max Healthcare Institute Ltd.
Historical Solvency Ratios
Loading ...
